Brief: Zylox-Tonbridge Medical Technology Announces Licensing & Investment Agreements With Avinger
07/03/2024 24:55
March 7 (Reuters) - Zylox-Tonbridge Medical Technology
Co Ltd 2190.HK :
* LICENSING AND INVESTMENT AGREEMENTS WITH AVINGER INC.
* UNDER AGREEMENT, CO WILL INVEST US$15.0 MLN INTO AVINGER
* UNDER DEAL, CO RECEIVES EXCLUSIVE RIGHT TO COMMERCIALIZE
OPTICAL
COHERENCE TOMOGRAPHY CONSOLES
Further company coverage: 2190.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avinger
See all newsBrief: Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance
Brief: Avinger Inc Has Terminated 36 Employees
Brief: Avinger Inc - On Nov 20, Received Nasdaq Non-Compliance Notice For Minimum Bid Price
Avinger Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Avinger Q3 Net Income USD -3.706 Million